Delivery Order SPE2DB24D1007-SPE2DB24FBZPT

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,732.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. It is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,047.18 firm fixed-price delivery order is for MESTINON 180 MG TIMESPAN UU 30S medication, with a period of performance through November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $2,304.73 with Amerisourcebergen Drug Corp as the prime contractor. The contract is for the supply of MESTINON 180 MG TIMESPAN medication, with a completion date of November 19, 2024. It is a Firm Fixed Price contract, with no set-aside designation indicated. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,691.14, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,167.76 Firm Fixed Price Delivery Order contract covers the provision of MESTINON 180 MG TIMESPAN medication to support military and federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, worth $18,728.40, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Mestinon 180 mg TimeSpan medication. This is a firm fixed-price delivery order contract with a completion date of May 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,643.08 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a medication used to treat myasthenia gravis. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,740.10, is for the delivery of Mestinon 180 mg Timespan medication. It is a firm fixed-price delivery order contract with a completion date of February 26, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,395.46 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a medication used to treat certain neurological conditions. The award has an ultimate completion date of January 28, 2025 and is not associated with a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award, valued at $12,756.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 27, 2025. The contract covers the procurement of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FBZPT
    Delivery Order

This federal contract award, valued at $2,029.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, with a performance period through June 4, 2024.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:05 PM